References

1. DeFronzo RA, Bonadonna RC, Ferrannini E (1992) Pathogenesis of NIDDM. A balanced overview. Diabetes Care 15: 318-368. View
2. Abdul-Ghani MA, Tripathy D, DeFronzo RA (2006) Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 29: 1130-1139. View
3. U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diaetes: a progressive disease. U.K. Prospective Diabetes Study Group. Diabetes 1995; 44:1249-1258.
4. Tahara Y, Shima K (1995) Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level. Diabetes Care 18: 440-447. View
5. Festa A, Williams K, Hanley AJG, Haffner SM (2008) β-Cell Dysfunction in Subjects With Impaired Glucose Tolerance and Early Type 2 Diabetes. Diabetes 57: 1638-1644. View
6. Cerasi E, Luft R (1963) Plasma-Insulin Response to Sustained Hyperglycemia Induced by Glucose Infusion in Human Subjects. Lancet 2: 1359-1361. View
7. Bergman RN, Phillips LS, Cobelli C (1981) Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and betacell glucose sensitivity from the response to intravenous glucose. J Clin Invest 68: 1456-1467. View
8. Leahy JL (1990) Natural history of beta-cell dysfunction in NIDDM. Diabetes Care 13: 992-1010. View
9. Polonsky KS, Sturis J, Bell GI (1996) Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus-a genetically programmed failure of the beta cell to compensate for insulin resistance. N Engl J Med 334: 777-783. View
10. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419. View
11. Pacini G, Bergman RN (1986) MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed 23: 113- 122. View
12. Gjessing HJ, Damsgaard EM, Matzen LE, Froland A, Faber OK (1987) Reproducibility of beta-cell function estimates in non-insulin-dependent diabetes mellitus. Diabetes Care 10: 558-562. View
13. Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Jarvinen H, et al. (2000) Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23: 295-301. View
14. DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237: E214-223. View
15. Byrne MM, Sturis J, Polonsky KS (1995) Insulin secretion and clearance during low-dose graded glucose infusion. Am J Physiol 268: E21-27. View
16. Larsson H, Ahren B (1998) Glucose-dependent arginine stimulation test for characterization of islet function: studies on reproducibility and priming effect of arginine. Diabetologia 41: 772-777. View
17. American Diabetes Association (2004) Screening for Type 2 Diabetes. Diabetes Care 27: S11-14. View
18. Bergman RN (1989) Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes 38: 1512-1527. View
19. Levy J, Atkinson AB, Bell PM, McCance DR, Hadden DR (1998) Beta-cell deterioration determines the onset and rate of progression of secondary dietary failure in type 2 diabetes mellitus: the 10-year follow-up of the Belfast Diet Study. Diabet Med 15: 290-296. View
20. Hollingdal M, Sturis J, Gall MA, Damsbo P, Pincus S, et al. (2005) Repaglinide treatment amplifies first-phase insulin secretion and high-frequency pulsatile insulin release in Type 2 diabetes. Diabet Med 22: 1408-1413. View
21. Rudovich NN, Leyck Dieken MG, Rochlitz H, Pfeiffer AF (2004) Enhancement of Early- and Late-Phase Insulin Secretion and Insulin Sensitivity by the Combination of Repaglinide and Metformin in Type 2 Diabetes Mellitus. Exp Clin Endocrinol Diabetes 112: 395-400. View
22. Kosaka K, Kuzuya T, Yoshinaga H, Hagura R (1996) A prospective study of health check examinees for the development of non-insulin-dependent diabetes mellitus: relationship of the incidence of diabetes with the initial insulinogenic index and degree of obesity. Diabet Med 13: S120-126. View
23. Pei D, Hsiao CF, Hung YJ, Hsieh CH, Fang SC, et al. (2006) The insulin sensitivity, glucose sensitivity, and acute insulin response to glucose load in adolescent type 2 diabetes in Taiwanese. Diabetes Metab Res Rev 22: 26-33. View
24. Unger RH, Grundy S (1985) Hyperglycaemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes. Diabetologia 28: 119-121. View
25. Dubois M, Kerr-Conte J, Gmyr V, Bouckenooghe T, Muharram G, et al. (2004) Non-esterified fatty acids are deleterious for human pancreatic islet function at physiological glucose concentration. Diabetologia 47: 463-469. View
26. Wajchenberg BL (2007) {beta}-Cell Failure in Diabetes and Preservation by Clinical Treatment. Endocr Rev 28: 187-218. View
27. Poitout V, Robertson RP (2008) Glucolipotoxicity: Fuel Excess and {beta}- Cell Dysfunction. Endocr Rev 29: 351-366. View